Indoritel Makmur Internasional Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Indoritel Makmur Internasional Tbk. trades at Rp9,800 (market cap 138.29T, 28.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Indoritel Makmur Internasional Tbk. is far larger — about 236.6× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 28.5K). Which is the better fit depends on your goals.
| DNET | LABS | |
|---|---|---|
Market Cap | 138.29T | 584.6B |
Volume | 28.5K | 817.3K |
Lot | 285 | 8.17K |
Turnover | 279.88M | 120.01M |
Average Price | 9,820.44 | 146.84 |
Value | 279.88M | 120.01M |
Indicative Equilibrium Price | 9,800 | 146 |
Indicative Equilibrium Volume | 100 | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indoritel Makmur International Tbk, (formerly PT. Dyviacom Intrabumi, Tbk) was established based on Notarial Deed of Siti Pertiwi Henny Singgih, S.H., No 107 dated November 16, 1995, and has a vision to take part in changing the proper lifestyle to the cyber technology era. In early 1997, The Company launched DIFFY.COM to extends its business.
Read more on DNET →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →